- Framework of problems / Transparent
- Funding or sponsor of systematic review not reported
- Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
| Ref ID | 459 |
| First Author | M. Roseman |
| Journal | BMJ |
| Year Of Publishing | 2012 |
| URL | https://www.bmj.com/content/bmj/345/bmj.e5155.full.pdf |
| Keywords |
Cochrane Transparency Pharmacological Allegiance Disclosure |
| Problem(s) |
Funding or sponsor of systematic review not reported Conflicts of interest or funding of included studies not assessed |
| Number of systematic reviews included | 151 |
| Summary of Findings | 30% of included reviews reported information on the funding sources of included trials, including 20% that reported information on trial funding for all included trials and 11% that reported for some, but not all, trials. Only 11% provided any information on trial author-industry financial ties or trial author-industry employment. Information on trial funding and trial author-industry ties was reported in one to seven locations within each review, with no consistent reporting location observed. |
| Did the article find that the problem(s) led to qualitative changes in interpretation of the results? | Not Applicable |
| Are the methods of the article described in enough detail to replicate the study? | No |